We have read with interest the recent publication of Aygören-Pürsün et al. (1) in which they ascribe 5 seroconversions for human parvovirus B19, among 16 previously untreated and susceptible persons receiving recombinant factor VIII, to possible B19 contamination of the albumin excipient. A more likely explanation, in the absence of a close temporal association with infusion of a particular product batch, is that this just represents community-acquired infection of this endemic virus, particularly in a group of young age. We have suggested this previously (2-4) and such an explanation would also be supported by a study we performed in 1995 showing similar age dependence of B19 seroprevalence in the Scottish population and Scots persons with haemophilia (Fig. 1), and by other studies that include an appropriate control group, such as that of Williams et al. (5).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.